{"transactions":[{"id":738321,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Series C Warrants","published_at":"2026-06-15T21:37:36.000Z","date":"2026-06-11","kind":"purchase","planned":false,"acquired":true,"shares":955414,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"The Series C Warrants have an exercise price equal to $3.14 per share of Common Stock or $3.139 per pre-funded warrant, are exercisable immediately, and will expire one year from the issuance date of the Series C Warrant."},{"field":"security","element":"securityTitle","label":"F5","text":"Under the terms of the Series B Warrants and the Series C Warrants, the Issuer may not effect the exercise of any portion thereof, and the JSB 2021 Trust will not have the right to exercise any portion thereof, which, upon giving effect to such exercise, would cause the JSB 2021 Trust (together with its affiliates) to own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise. To the extent that exercise of the Series B Warrants or Series C Warrants will result in the JSB 2021 Trust (together with its affiliates) beneficially owning shares of Common Stock above such ownership limitations, the JSB 2021 Trust may exercise its Series B Warrants or Series C Warrants for pre-funded warrants to purchase shares of Common Stock, which pre-funded warrants will include a substantially similar maximum ownership limitation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 11, 2026, the Issuer completed a private placement (the \"Private Placement\") pursuant to a securities purchase agreement, dated June 9, 2026 (the \"Purchase Agreement\"), with the Joshua S. Boger 2021 Trust DTD 12/09/2021, of which the Reporting Person serves as the sole trustee (the \"JSB 2021 Trust\"), and certain accredited investors named therein. Pursuant to the Purchase Agreement, the JSB 2021 Trust purchased an aggregate of 955,414 units (the \"Units\"), each Unit comprised of (i) one share of the Issuer's common stock, par value $0.001 per share (the \"Common Stock\"), (ii) one Series B warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series B Warrant\"), and (iii) one Series C warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series C Warrant\") for a purchase price of $3.14 per Unit."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Series B Warrants and Series C Warrants are owned by the JSB 2021 Trust."}],"balance_after":955414,"derivative":{"exercise_price":3.14,"exercise_date":"2026-06-11","expiration_date":"2027-06-11","underlying":"Common Stock","underlying_shares":955414},"source":{"system":"sec-edgar","filing":"0001437749-26-020691","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020691/rdgdoc.xml","form_type":"4"}},{"id":738320,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Series B Warrants","published_at":"2026-06-15T21:37:36.000Z","date":"2026-06-11","kind":"purchase","planned":false,"acquired":true,"shares":955414,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The Series B Warrants have an exercise price equal to $3.32 per share of Common Stock or $3.319 per pre-funded warrant, are exercisable immediately, and will expire five years from the issuance date of the Series B Warrant."},{"field":"security","element":"securityTitle","label":"F5","text":"Under the terms of the Series B Warrants and the Series C Warrants, the Issuer may not effect the exercise of any portion thereof, and the JSB 2021 Trust will not have the right to exercise any portion thereof, which, upon giving effect to such exercise, would cause the JSB 2021 Trust (together with its affiliates) to own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise. To the extent that exercise of the Series B Warrants or Series C Warrants will result in the JSB 2021 Trust (together with its affiliates) beneficially owning shares of Common Stock above such ownership limitations, the JSB 2021 Trust may exercise its Series B Warrants or Series C Warrants for pre-funded warrants to purchase shares of Common Stock, which pre-funded warrants will include a substantially similar maximum ownership limitation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 11, 2026, the Issuer completed a private placement (the \"Private Placement\") pursuant to a securities purchase agreement, dated June 9, 2026 (the \"Purchase Agreement\"), with the Joshua S. Boger 2021 Trust DTD 12/09/2021, of which the Reporting Person serves as the sole trustee (the \"JSB 2021 Trust\"), and certain accredited investors named therein. Pursuant to the Purchase Agreement, the JSB 2021 Trust purchased an aggregate of 955,414 units (the \"Units\"), each Unit comprised of (i) one share of the Issuer's common stock, par value $0.001 per share (the \"Common Stock\"), (ii) one Series B warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series B Warrant\"), and (iii) one Series C warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series C Warrant\") for a purchase price of $3.14 per Unit."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Series B Warrants and Series C Warrants are owned by the JSB 2021 Trust."}],"balance_after":955414,"derivative":{"exercise_price":3.32,"exercise_date":"2026-06-11","expiration_date":"2031-06-11","underlying":"Common Stock","underlying_shares":955414},"source":{"system":"sec-edgar","filing":"0001437749-26-020691","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020691/rdgdoc.xml","form_type":"4"}},{"id":738319,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2026-06-15T21:37:36.000Z","date":"2026-06-11","kind":"purchase","planned":false,"acquired":true,"shares":955414,"price":3.14,"value":2999999.96,"ownership":{"direct":false,"nature":"By Trusts"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 11, 2026, the Issuer completed a private placement (the \"Private Placement\") pursuant to a securities purchase agreement, dated June 9, 2026 (the \"Purchase Agreement\"), with the Joshua S. Boger 2021 Trust DTD 12/09/2021, of which the Reporting Person serves as the sole trustee (the \"JSB 2021 Trust\"), and certain accredited investors named therein. Pursuant to the Purchase Agreement, the JSB 2021 Trust purchased an aggregate of 955,414 units (the \"Units\"), each Unit comprised of (i) one share of the Issuer's common stock, par value $0.001 per share (the \"Common Stock\"), (ii) one Series B warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series B Warrant\"), and (iii) one Series C warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series C Warrant\") for a purchase price of $3.14 per Unit."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 11, 2026, the Issuer completed a private placement (the \"Private Placement\") pursuant to a securities purchase agreement, dated June 9, 2026 (the \"Purchase Agreement\"), with the Joshua S. Boger 2021 Trust DTD 12/09/2021, of which the Reporting Person serves as the sole trustee (the \"JSB 2021 Trust\"), and certain accredited investors named therein. Pursuant to the Purchase Agreement, the JSB 2021 Trust purchased an aggregate of 955,414 units (the \"Units\"), each Unit comprised of (i) one share of the Issuer's common stock, par value $0.001 per share (the \"Common Stock\"), (ii) one Series B warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series B Warrant\"), and (iii) one Series C warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series C Warrant\") for a purchase price of $3.14 per Unit."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"After giving effect to all transactions described herein, consists of (i) 1,600,117 shares of the Issuer's common stock held by the JSB 2021 Trust and (ii) 195,748 shares of the Issuer's common stock held by The Amy S. Boger 2021 Trust (the \"ASB 2021 Trust\"). The Reporting Person serves as the sole trustee of each of the JSB 2021 Trust and the ASB 2021 Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":1795865,"source":{"system":"sec-edgar","filing":"0001437749-26-020691","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020691/rdgdoc.xml","form_type":"4"}},{"id":743652,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T23:42:37.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":8150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 8, 2026, in connection with the Reporting Person's election to the Issuer's board of directors at its 2026 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,150 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8150,"derivative":{"exercise_price":2.91,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":8150},"source":{"system":"sec-edgar","filing":"0001437749-26-020211","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020211/rdgdoc.xml","form_type":"4"}},{"id":1101916,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:03:28.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":8100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 23, 2025, in connection with the Reporting Person's election to the Issuer's board of directors at its 2025 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,100 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8100,"derivative":{"exercise_price":6.52,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":8100},"source":{"system":"sec-edgar","filing":"0001437749-25-021273","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925021273/rdgdoc.xml","form_type":"4"}},{"id":1479593,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T22:27:20.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 14, 2024, in connection with the Reporting Person's election to the Issuer's board of directors at its 2024 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 5,750 shares of the Issuer's common stock under the Issuer's 2015 Equity Incentive Plan, as amended, in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":5750,"derivative":{"exercise_price":19.01,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001437749-24-020413","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924020413/rdgdoc.xml","form_type":"4"}},{"id":1613067,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Pre-Funded Common Stock Purchase Warrant","published_at":"2024-02-28T22:02:49.000Z","date":"2024-02-26","kind":"other","planned":false,"acquired":false,"shares":495995,"ownership":{"direct":false,"nature":"By Trusts"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 26, 2024, a pre-funded common stock purchase warrant to purchase 495,995 shares of the Issuer's common stock (as amended, the \"Pre-Funded Warrant\") held by the JSB 2021 Trust (as defined below) was amended and subsequently exercised in full on a cashless basis. In accordance with the terms of the Pre-Funded Warrant, 36 shares of the Issuer's common stock were withheld in lieu of a cash payment of the exercise price and the JSB 2021 Trust was issued the remaining 495,959 shares of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Consists of shares of the Issuer's common stock underlying the previously issued Pre-Funded Warrant. The Pre-Funded Warrant is exercisable at any time after the date of issuance and the pre-funded warrants do not expire."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Consists of shares of the Issuer's common stock underlying the previously issued Pre-Funded Warrant. The Pre-Funded Warrant is exercisable at any time after the date of issuance and the pre-funded warrants do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Consists of shares of the Issuer's common stock underlying the previously issued Pre-Funded Warrant. The Pre-Funded Warrant is exercisable at any time after the date of issuance and the pre-funded warrants do not expire."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"After giving effect to all transactions described herein, consists of (i) 644,703 shares of the Issuer's common stock held by The Joshua S. Boger 2021 Trust DTD 12/09/2021 (the \"JSB 2021 Trust\") and (ii) 195,748 shares of the Issuer's common stock held by The Amy S. Boger 2021 Trust (the \"ASB 2021 Trust\"). The Reporting Person serves as the sole trustee of each of the JSB 2021 Trust and the ASB 2021 Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":0.001,"underlying":"Common Stock","underlying_shares":495995},"source":{"system":"sec-edgar","filing":"0001437749-24-005918","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924005918/rdgdoc.xml","form_type":"4"}},{"id":1613066,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-02-28T22:02:49.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":36,"ownership":{"direct":false,"nature":"By Trusts"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 26, 2024, a pre-funded common stock purchase warrant to purchase 495,995 shares of the Issuer's common stock (as amended, the \"Pre-Funded Warrant\") held by the JSB 2021 Trust (as defined below) was amended and subsequently exercised in full on a cashless basis. In accordance with the terms of the Pre-Funded Warrant, 36 shares of the Issuer's common stock were withheld in lieu of a cash payment of the exercise price and the JSB 2021 Trust was issued the remaining 495,959 shares of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 26, 2024, a pre-funded common stock purchase warrant to purchase 495,995 shares of the Issuer's common stock (as amended, the \"Pre-Funded Warrant\") held by the JSB 2021 Trust (as defined below) was amended and subsequently exercised in full on a cashless basis. In accordance with the terms of the Pre-Funded Warrant, 36 shares of the Issuer's common stock were withheld in lieu of a cash payment of the exercise price and the JSB 2021 Trust was issued the remaining 495,959 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"After giving effect to all transactions described herein, consists of (i) 644,703 shares of the Issuer's common stock held by The Joshua S. Boger 2021 Trust DTD 12/09/2021 (the \"JSB 2021 Trust\") and (ii) 195,748 shares of the Issuer's common stock held by The Amy S. Boger 2021 Trust (the \"ASB 2021 Trust\"). The Reporting Person serves as the sole trustee of each of the JSB 2021 Trust and the ASB 2021 Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":840451,"source":{"system":"sec-edgar","filing":"0001437749-24-005918","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924005918/rdgdoc.xml","form_type":"4"}},{"id":1613065,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-02-28T22:02:49.000Z","date":"2024-02-26","kind":"other","planned":false,"acquired":true,"shares":495995,"ownership":{"direct":false,"nature":"By Trusts"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2024, a pre-funded common stock purchase warrant to purchase 495,995 shares of the Issuer's common stock (as amended, the \"Pre-Funded Warrant\") held by the JSB 2021 Trust (as defined below) was amended and subsequently exercised in full on a cashless basis. In accordance with the terms of the Pre-Funded Warrant, 36 shares of the Issuer's common stock were withheld in lieu of a cash payment of the exercise price and the JSB 2021 Trust was issued the remaining 495,959 shares of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 26, 2024, a pre-funded common stock purchase warrant to purchase 495,995 shares of the Issuer's common stock (as amended, the \"Pre-Funded Warrant\") held by the JSB 2021 Trust (as defined below) was amended and subsequently exercised in full on a cashless basis. In accordance with the terms of the Pre-Funded Warrant, 36 shares of the Issuer's common stock were withheld in lieu of a cash payment of the exercise price and the JSB 2021 Trust was issued the remaining 495,959 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"After giving effect to all transactions described herein, consists of (i) 644,703 shares of the Issuer's common stock held by The Joshua S. Boger 2021 Trust DTD 12/09/2021 (the \"JSB 2021 Trust\") and (ii) 195,748 shares of the Issuer's common stock held by The Amy S. Boger 2021 Trust (the \"ASB 2021 Trust\"). The Reporting Person serves as the sole trustee of each of the JSB 2021 Trust and the ASB 2021 Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":840487,"source":{"system":"sec-edgar","filing":"0001437749-24-005918","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924005918/rdgdoc.xml","form_type":"4"}},{"id":1646970,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-13T21:39:58.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 12, 2024, in connection with the Reporting Person's initial election to the Issuer's board of directors, the Reporting Person was granted an option to purchase 10,000 shares of the Issuer's common stock under the Issuer's 2015 Equity Incentive Plan, as amended, in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a three-year period in substantially equal 1/36th increments on the last day of each month beginning on February 29, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":13.97,"expiration_date":"2034-02-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-003927","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924003927/rdgdoc.xml","form_type":"4"}},{"id":425540,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2017-06-09T20:31:56.000Z","date":"2017-06-08","kind":"exercise","acquired":false,"shares":2941,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and converted into common stock upon the termination of Dr. Boger's service on our board of directors on 06/08/2017."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents one share of common stock and converted into common stock upon the termination of Dr. Boger's service on our board of directors on 06/08/2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and converted into common stock upon the termination of Dr. Boger's service on our board of directors on 06/08/2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and converted into common stock upon the termination of Dr. Boger's service on our board of directors on 06/08/2017."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2941},"source":{"system":"sec-edgar","filing":"0001209191-17-038895","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117038895/doc4.xml","form_type":"4"}},{"id":425539,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-09T20:31:56.000Z","date":"2017-06-08","kind":"exercise","acquired":true,"shares":2941,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents one share of common stock and converted into common stock upon the termination of Dr. Boger's service on our board of directors on 06/08/2017."}],"balance_after":284088,"source":{"system":"sec-edgar","filing":"0001209191-17-038895","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117038895/doc4.xml","form_type":"4"}},{"id":425820,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2017-06-05T21:09:09.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":2941,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Boger's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Boger's disability or death."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the vesting of restricted stock units granted to Dr. Boger on June 1, 2016, Dr. Boger deferred the receipt of 2,941 shares of common stock and received instead 2,941 deferred stock units pursuant to the Company's deferred compensation plan. As a result, Dr. Boger is reporting the disposition of 2,941 shares of common stock in exchange for an equal number of deferred stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Boger's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Boger's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Boger's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Boger's disability or death."}],"balance_after":2941,"derivative":{"underlying":"Common Stock","underlying_shares":2941},"source":{"system":"sec-edgar","filing":"0001209191-17-037808","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117037808/doc4.xml","form_type":"4"}},{"id":425819,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-05T21:09:09.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":5295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":5295,"derivative":{"exercise_price":125.71,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":5295},"source":{"system":"sec-edgar","filing":"0001209191-17-037808","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117037808/doc4.xml","form_type":"4"}},{"id":425818,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-05T21:09:09.000Z","date":"2017-06-01","kind":"disposition_to_issuer","acquired":false,"shares":2941,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the vesting of restricted stock units granted to Dr. Boger on June 1, 2016, Dr. Boger deferred the receipt of 2,941 shares of common stock and received instead 2,941 deferred stock units pursuant to the Company's deferred compensation plan. As a result, Dr. Boger is reporting the disposition of 2,941 shares of common stock in exchange for an equal number of deferred stock units."}],"balance_after":281147,"source":{"system":"sec-edgar","filing":"0001209191-17-037808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117037808/doc4.xml","form_type":"4"}},{"id":425817,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-05T21:09:09.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":2188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":284088,"source":{"system":"sec-edgar","filing":"0001209191-17-037808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117037808/doc4.xml","form_type":"4"}},{"id":431854,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-13T21:12:22.000Z","date":"2017-01-11","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-17-003660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117003660/doc4.xml","form_type":"4"}},{"id":431853,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-13T21:12:22.000Z","date":"2017-01-11","kind":"sale","acquired":false,"shares":500,"price":84.98,"value":42490.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $84.98 (range $84.87 to $85.11)."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-17-003660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117003660/doc4.xml","form_type":"4"}},{"id":431852,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-13T21:12:22.000Z","date":"2017-01-11","kind":"sale","acquired":false,"shares":1100,"price":84.41,"value":92851.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $84.41 (range $83.72 to $84.70)."}],"balance_after":268725,"source":{"system":"sec-edgar","filing":"0001209191-17-003660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117003660/doc4.xml","form_type":"4"}},{"id":431851,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-13T21:12:22.000Z","date":"2017-01-11","kind":"sale","acquired":false,"shares":1100,"price":82.92,"value":91212.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $82.92 (range $82.64 to $83.24)."}],"balance_after":269825,"source":{"system":"sec-edgar","filing":"0001209191-17-003660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117003660/doc4.xml","form_type":"4"}},{"id":431850,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-13T21:12:22.000Z","date":"2017-01-11","kind":"sale","acquired":false,"shares":2900,"price":82.17,"value":238293.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $82.17 (range $81.62 to $82.55)."}],"balance_after":270925,"source":{"system":"sec-edgar","filing":"0001209191-17-003660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117003660/doc4.xml","form_type":"4"}},{"id":431849,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-13T21:12:22.000Z","date":"2017-01-11","kind":"sale","acquired":false,"shares":2400,"price":81.25,"value":195000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $81.25 (range $80.61 to $81.60)."}],"balance_after":273825,"source":{"system":"sec-edgar","filing":"0001209191-17-003660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117003660/doc4.xml","form_type":"4"}},{"id":431848,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-13T21:12:22.000Z","date":"2017-01-11","kind":"exercise","acquired":true,"shares":8000,"price":36.3,"value":290400.0,"ownership":{"direct":true},"balance_after":276225,"source":{"system":"sec-edgar","filing":"0001209191-17-003660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117003660/doc4.xml","form_type":"4"}},{"id":431945,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-06T18:29:38.000Z","date":"2017-01-04","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":8000,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-17-002576","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117002576/doc4.xml","form_type":"4"}},{"id":431944,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-06T18:29:38.000Z","date":"2017-01-04","kind":"sale","acquired":false,"shares":1900,"price":77.69,"value":147611.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $77.69 (range $77.41 to $78.04)."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-17-002576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117002576/doc4.xml","form_type":"4"}},{"id":431943,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-06T18:29:38.000Z","date":"2017-01-04","kind":"sale","acquired":false,"shares":4400,"price":76.95,"value":338580.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $76.95 (range $76.35 to $77.28)."}],"balance_after":270125,"source":{"system":"sec-edgar","filing":"0001209191-17-002576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117002576/doc4.xml","form_type":"4"}},{"id":431942,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-06T18:29:38.000Z","date":"2017-01-04","kind":"sale","acquired":false,"shares":200,"price":75.64,"value":15128.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $75.64 (range $75.22 to $76.06)."}],"balance_after":274525,"source":{"system":"sec-edgar","filing":"0001209191-17-002576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117002576/doc4.xml","form_type":"4"}},{"id":431941,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-06T18:29:38.000Z","date":"2017-01-04","kind":"exercise","acquired":true,"shares":6500,"price":36.3,"value":235950.0,"ownership":{"direct":true},"balance_after":274725,"source":{"system":"sec-edgar","filing":"0001209191-17-002576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117002576/doc4.xml","form_type":"4"}},{"id":432348,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-03T21:40:40.000Z","date":"2016-12-29","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."}],"balance_after":14500,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-17-000287","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117000287/doc4.xml","form_type":"4"}},{"id":432347,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-03T21:40:40.000Z","date":"2016-12-29","kind":"sale","acquired":false,"shares":800,"price":74.86,"value":59888.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $74.86 (range $74.80 to $74.91)."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-17-000287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117000287/doc4.xml","form_type":"4"}},{"id":432346,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-03T21:40:40.000Z","date":"2016-12-29","kind":"sale","acquired":false,"shares":5700,"price":74.25,"value":423225.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $74.25 (range $73.76 to $74.75)."}],"balance_after":269025,"source":{"system":"sec-edgar","filing":"0001209191-17-000287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117000287/doc4.xml","form_type":"4"}},{"id":432345,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-03T21:40:40.000Z","date":"2016-12-29","kind":"exercise","acquired":true,"shares":6500,"price":36.3,"value":235950.0,"ownership":{"direct":true},"balance_after":274725,"source":{"system":"sec-edgar","filing":"0001209191-17-000287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919117000287/doc4.xml","form_type":"4"}},{"id":432413,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-22T15:30:10.000Z","date":"2016-12-21","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully vested."}],"balance_after":21000,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-16-156413","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116156413/doc4.xml","form_type":"4"}},{"id":432412,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-22T15:30:10.000Z","date":"2016-12-21","kind":"sale","acquired":false,"shares":300,"price":76.39,"value":22917.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $76.39 (range $76.13 to $76.52)."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-16-156413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116156413/doc4.xml","form_type":"4"}},{"id":432411,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-22T15:30:10.000Z","date":"2016-12-21","kind":"sale","acquired":false,"shares":800,"price":75.61,"value":60488.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $75.61 (range $75.12 to $76.03)."}],"balance_after":268525,"source":{"system":"sec-edgar","filing":"0001209191-16-156413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116156413/doc4.xml","form_type":"4"}},{"id":432410,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-22T15:30:10.000Z","date":"2016-12-21","kind":"sale","acquired":false,"shares":1300,"price":74.35,"value":96655.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $74.35 (range $74.07 to $75.00)."}],"balance_after":269325,"source":{"system":"sec-edgar","filing":"0001209191-16-156413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116156413/doc4.xml","form_type":"4"}},{"id":432409,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-22T15:30:10.000Z","date":"2016-12-21","kind":"sale","acquired":false,"shares":4100,"price":73.65,"value":301965.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $73.65 (range $73.06 to $74.05)."}],"balance_after":270625,"source":{"system":"sec-edgar","filing":"0001209191-16-156413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116156413/doc4.xml","form_type":"4"}},{"id":432408,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-22T15:30:10.000Z","date":"2016-12-21","kind":"exercise","acquired":true,"shares":6500,"price":36.3,"value":235950.0,"ownership":{"direct":true},"balance_after":274725,"source":{"system":"sec-edgar","filing":"0001209191-16-156413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116156413/doc4.xml","form_type":"4"}},{"id":432521,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-16T20:03:37.000Z","date":"2016-12-14","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."}],"balance_after":27500,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-16-155612","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116155612/doc4.xml","form_type":"4"}},{"id":432520,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-16T20:03:37.000Z","date":"2016-12-14","kind":"sale","acquired":false,"shares":800,"price":78.22,"value":62576.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $78.22 (range $77.89 to $78.57)."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-16-155612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116155612/doc4.xml","form_type":"4"}},{"id":432519,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-16T20:03:37.000Z","date":"2016-12-14","kind":"sale","acquired":false,"shares":5700,"price":77.42,"value":441294.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $77.42 (range $76.89 to $77.84)."}],"balance_after":269025,"source":{"system":"sec-edgar","filing":"0001209191-16-155612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116155612/doc4.xml","form_type":"4"}},{"id":432518,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-16T20:03:37.000Z","date":"2016-12-14","kind":"exercise","acquired":true,"shares":6500,"price":36.3,"value":235950.0,"ownership":{"direct":true},"balance_after":274725,"source":{"system":"sec-edgar","filing":"0001209191-16-155612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116155612/doc4.xml","form_type":"4"}},{"id":432739,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-09T19:17:23.000Z","date":"2016-12-07","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."}],"balance_after":34000,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-16-154333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116154333/doc4.xml","form_type":"4"}},{"id":432738,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-09T19:17:23.000Z","date":"2016-12-07","kind":"sale","acquired":false,"shares":100,"price":76.2,"value":7620.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-16-154333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116154333/doc4.xml","form_type":"4"}},{"id":432737,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-09T19:17:23.000Z","date":"2016-12-07","kind":"sale","acquired":false,"shares":3800,"price":75.48,"value":286824.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $75.48 (range $75.17 to $76.13)."}],"balance_after":268325,"source":{"system":"sec-edgar","filing":"0001209191-16-154333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116154333/doc4.xml","form_type":"4"}},{"id":432736,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-09T19:17:23.000Z","date":"2016-12-07","kind":"sale","acquired":false,"shares":2600,"price":74.63,"value":194038.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $74.63 (range $74.15 to $75.12)."}],"balance_after":272125,"source":{"system":"sec-edgar","filing":"0001209191-16-154333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116154333/doc4.xml","form_type":"4"}},{"id":432735,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-09T19:17:23.000Z","date":"2016-12-07","kind":"exercise","acquired":true,"shares":6500,"price":36.3,"value":235950.0,"ownership":{"direct":true},"balance_after":274725,"source":{"system":"sec-edgar","filing":"0001209191-16-154333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116154333/doc4.xml","form_type":"4"}},{"id":432854,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-02T19:22:37.000Z","date":"2016-11-30","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully vested."}],"balance_after":40500,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-16-152916","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116152916/doc4.xml","form_type":"4"}},{"id":432853,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-02T19:22:37.000Z","date":"2016-11-30","kind":"sale","acquired":false,"shares":500,"price":85.53,"value":42765.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $85.53 (range $85.35 to $85.85)."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-16-152916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116152916/doc4.xml","form_type":"4"}},{"id":432852,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-02T19:22:37.000Z","date":"2016-11-30","kind":"sale","acquired":false,"shares":1700,"price":84.53,"value":143701.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $84.53 (range $84.14 to $85.00)."}],"balance_after":268725,"source":{"system":"sec-edgar","filing":"0001209191-16-152916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116152916/doc4.xml","form_type":"4"}},{"id":432851,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-02T19:22:37.000Z","date":"2016-11-30","kind":"sale","acquired":false,"shares":2100,"price":83.48,"value":175308.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $83.48 (range $82.97 to $83.80)."}],"balance_after":270425,"source":{"system":"sec-edgar","filing":"0001209191-16-152916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116152916/doc4.xml","form_type":"4"}},{"id":432850,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-02T19:22:37.000Z","date":"2016-11-30","kind":"sale","acquired":false,"shares":2200,"price":82.2,"value":180840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $82.20 (range $81.90 to $82.74)."}],"balance_after":272525,"source":{"system":"sec-edgar","filing":"0001209191-16-152916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116152916/doc4.xml","form_type":"4"}},{"id":432849,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-02T19:22:37.000Z","date":"2016-11-30","kind":"exercise","acquired":true,"shares":6500,"price":36.3,"value":235950.0,"ownership":{"direct":true},"balance_after":274725,"source":{"system":"sec-edgar","filing":"0001209191-16-152916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116152916/doc4.xml","form_type":"4"}},{"id":433062,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-28T21:20:11.000Z","date":"2016-11-23","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":47000,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-16-152183","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116152183/doc4.xml","form_type":"4"}},{"id":433061,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-28T21:20:11.000Z","date":"2016-11-23","kind":"sale","acquired":false,"shares":2000,"price":86.98,"value":173960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $86.98 (range $86.79 to $87.40)."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-16-152183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116152183/doc4.xml","form_type":"4"}},{"id":433060,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-28T21:20:11.000Z","date":"2016-11-23","kind":"sale","acquired":false,"shares":3900,"price":86.43,"value":337077.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $86.43 (range $85.78 to $86.76)."}],"balance_after":270225,"source":{"system":"sec-edgar","filing":"0001209191-16-152183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116152183/doc4.xml","form_type":"4"}},{"id":433059,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-28T21:20:11.000Z","date":"2016-11-23","kind":"sale","acquired":false,"shares":600,"price":85.01,"value":51006.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $85.01 (range $84.44 to $85.38)."}],"balance_after":274125,"source":{"system":"sec-edgar","filing":"0001209191-16-152183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116152183/doc4.xml","form_type":"4"}},{"id":433058,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-28T21:20:11.000Z","date":"2016-11-23","kind":"exercise","acquired":true,"shares":6500,"price":36.3,"value":235950.0,"ownership":{"direct":true},"balance_after":274725,"source":{"system":"sec-edgar","filing":"0001209191-16-152183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116152183/doc4.xml","form_type":"4"}},{"id":433427,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-17T21:35:31.000Z","date":"2016-11-16","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."}],"balance_after":53500,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-16-150889","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116150889/doc4.xml","form_type":"4"}},{"id":433426,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-17T21:35:31.000Z","date":"2016-11-16","kind":"sale","acquired":false,"shares":4563,"price":91.75,"value":418655.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $91.75 (range $91.47 to $92.03)."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-16-150889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116150889/doc4.xml","form_type":"4"}},{"id":433425,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-17T21:35:31.000Z","date":"2016-11-16","kind":"sale","acquired":false,"shares":1937,"price":91.07,"value":176402.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $91.07 (range $90.47 to $91.46)."}],"balance_after":272788,"source":{"system":"sec-edgar","filing":"0001209191-16-150889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116150889/doc4.xml","form_type":"4"}},{"id":433424,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-17T21:35:31.000Z","date":"2016-11-16","kind":"exercise","acquired":true,"shares":6500,"price":36.3,"value":235950.0,"ownership":{"direct":true},"balance_after":274725,"source":{"system":"sec-edgar","filing":"0001209191-16-150889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116150889/doc4.xml","form_type":"4"}},{"id":433646,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-14T13:41:30.000Z","date":"2016-11-09","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Fully vested."}],"balance_after":60000,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-16-149542","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116149542/doc4.xml","form_type":"4"}},{"id":433645,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-14T13:41:30.000Z","date":"2016-11-09","kind":"sale","acquired":false,"shares":900,"price":93.04,"value":83736.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $93.04 (range $92.84 to $93.47)."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-16-149542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116149542/doc4.xml","form_type":"4"}},{"id":433644,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-14T13:41:30.000Z","date":"2016-11-09","kind":"sale","acquired":false,"shares":1400,"price":92.1,"value":128940.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $92.10 (range $91.73 to $92.72)."}],"balance_after":269125,"source":{"system":"sec-edgar","filing":"0001209191-16-149542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116149542/doc4.xml","form_type":"4"}},{"id":433643,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-14T13:41:30.000Z","date":"2016-11-09","kind":"sale","acquired":false,"shares":1500,"price":91.11,"value":136665.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $91.11 (range $90.73 to $91.60)."}],"balance_after":270525,"source":{"system":"sec-edgar","filing":"0001209191-16-149542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116149542/doc4.xml","form_type":"4"}},{"id":433642,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-14T13:41:30.000Z","date":"2016-11-09","kind":"sale","acquired":false,"shares":1900,"price":90.13,"value":171247.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $90.13 (range $89.59 to $90.49)."}],"balance_after":272025,"source":{"system":"sec-edgar","filing":"0001209191-16-149542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116149542/doc4.xml","form_type":"4"}},{"id":433641,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-14T13:41:30.000Z","date":"2016-11-09","kind":"sale","acquired":false,"shares":800,"price":88.48,"value":70784.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $88.48 (range $88.18 to $89.00)."}],"balance_after":273925,"source":{"system":"sec-edgar","filing":"0001209191-16-149542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116149542/doc4.xml","form_type":"4"}},{"id":433640,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-14T13:41:30.000Z","date":"2016-11-09","kind":"exercise","acquired":true,"shares":6500,"price":36.3,"value":235950.0,"ownership":{"direct":true},"balance_after":274725,"source":{"system":"sec-edgar","filing":"0001209191-16-149542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116149542/doc4.xml","form_type":"4"}},{"id":434076,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-04T20:23:12.000Z","date":"2016-11-02","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."}],"balance_after":66500,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-16-148419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116148419/doc4.xml","form_type":"4"}},{"id":434075,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-04T20:23:12.000Z","date":"2016-11-02","kind":"sale","acquired":false,"shares":4000,"price":78.05,"value":312200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $78.05 (range $77.83 to $78.39)."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-16-148419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116148419/doc4.xml","form_type":"4"}},{"id":434074,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-04T20:23:12.000Z","date":"2016-11-02","kind":"sale","acquired":false,"shares":2500,"price":77.28,"value":193200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $77.28 (range $76.82 to $77.77)."}],"balance_after":272225,"source":{"system":"sec-edgar","filing":"0001209191-16-148419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116148419/doc4.xml","form_type":"4"}},{"id":434073,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-04T20:23:12.000Z","date":"2016-11-02","kind":"exercise","acquired":true,"shares":6500,"price":36.3,"value":235950.0,"ownership":{"direct":true},"balance_after":274725,"source":{"system":"sec-edgar","filing":"0001209191-16-148419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116148419/doc4.xml","form_type":"4"}},{"id":434272,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-10-28T17:12:52.000Z","date":"2016-10-26","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully vested."}],"balance_after":73000,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-16-147236","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116147236/doc4.xml","form_type":"4"}},{"id":434271,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-28T17:12:52.000Z","date":"2016-10-26","kind":"sale","acquired":false,"shares":100,"price":81.85,"value":8185.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-16-147236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116147236/doc4.xml","form_type":"4"}},{"id":434270,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-28T17:12:52.000Z","date":"2016-10-26","kind":"sale","acquired":false,"shares":1600,"price":80.74,"value":129184.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $80.74 (range $80.45 to $81.19)."}],"balance_after":268325,"source":{"system":"sec-edgar","filing":"0001209191-16-147236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116147236/doc4.xml","form_type":"4"}},{"id":434269,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-28T17:12:52.000Z","date":"2016-10-26","kind":"sale","acquired":false,"shares":1100,"price":80.06,"value":88066.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $80.06 (range $79.43 to $80.41)."}],"balance_after":269925,"source":{"system":"sec-edgar","filing":"0001209191-16-147236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116147236/doc4.xml","form_type":"4"}},{"id":434268,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-28T17:12:52.000Z","date":"2016-10-26","kind":"sale","acquired":false,"shares":1700,"price":78.92,"value":134164.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $78.92 (range $78.33 to $79.23)."}],"balance_after":271025,"source":{"system":"sec-edgar","filing":"0001209191-16-147236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116147236/doc4.xml","form_type":"4"}},{"id":434267,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-28T17:12:52.000Z","date":"2016-10-26","kind":"sale","acquired":false,"shares":2000,"price":77.8,"value":155600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $77.80 (range $77.31 to $78.25)."}],"balance_after":272725,"source":{"system":"sec-edgar","filing":"0001209191-16-147236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116147236/doc4.xml","form_type":"4"}},{"id":434266,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-28T17:12:52.000Z","date":"2016-10-26","kind":"exercise","acquired":true,"shares":6500,"price":36.3,"value":235950.0,"ownership":{"direct":true},"balance_after":274725,"source":{"system":"sec-edgar","filing":"0001209191-16-147236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116147236/doc4.xml","form_type":"4"}},{"id":434403,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-10-21T16:50:24.000Z","date":"2016-10-19","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":79500,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-16-146552","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116146552/doc4.xml","form_type":"4"}},{"id":434402,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-21T16:50:24.000Z","date":"2016-10-19","kind":"sale","acquired":false,"shares":200,"price":82.55,"value":16510.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-16-146552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116146552/doc4.xml","form_type":"4"}},{"id":434401,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-21T16:50:24.000Z","date":"2016-10-19","kind":"sale","acquired":false,"shares":6300,"price":81.82,"value":515466.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $81.82 (range $81.37 to $82.35)."}],"balance_after":268425,"source":{"system":"sec-edgar","filing":"0001209191-16-146552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116146552/doc4.xml","form_type":"4"}},{"id":434400,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-21T16:50:24.000Z","date":"2016-10-19","kind":"exercise","acquired":true,"shares":6500,"price":36.3,"value":235950.0,"ownership":{"direct":true},"balance_after":274725,"source":{"system":"sec-edgar","filing":"0001209191-16-146552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116146552/doc4.xml","form_type":"4"}},{"id":434465,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-10-14T15:53:56.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":86000,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-16-145887","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116145887/doc4.xml","form_type":"4"}},{"id":434464,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-14T15:53:56.000Z","date":"2016-10-12","kind":"sale","acquired":false,"shares":1000,"price":82.35,"value":82350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $82.35 (range $82.20 to $82.57)."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-16-145887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116145887/doc4.xml","form_type":"4"}},{"id":434463,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-14T15:53:56.000Z","date":"2016-10-12","kind":"sale","acquired":false,"shares":1400,"price":81.28,"value":113792.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $81.28 (range $81.16 to $81.94)."}],"balance_after":269225,"source":{"system":"sec-edgar","filing":"0001209191-16-145887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116145887/doc4.xml","form_type":"4"}},{"id":434462,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-14T15:53:56.000Z","date":"2016-10-12","kind":"sale","acquired":false,"shares":4100,"price":80.79,"value":331239.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $80.79 (range $80.13 to $81.12)."}],"balance_after":270625,"source":{"system":"sec-edgar","filing":"0001209191-16-145887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116145887/doc4.xml","form_type":"4"}},{"id":434461,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-14T15:53:56.000Z","date":"2016-10-12","kind":"exercise","acquired":true,"shares":6500,"price":36.3,"value":235950.0,"ownership":{"direct":true},"balance_after":274725,"source":{"system":"sec-edgar","filing":"0001209191-16-145887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116145887/doc4.xml","form_type":"4"}},{"id":434529,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-10-07T15:56:02.000Z","date":"2016-10-05","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."}],"balance_after":92500,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-16-145346","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116145346/doc4.xml","form_type":"4"}},{"id":434528,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-07T15:56:02.000Z","date":"2016-10-05","kind":"sale","acquired":false,"shares":5700,"price":87.55,"value":499035.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $87.55 (range $87.27 to $88.05)."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-16-145346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116145346/doc4.xml","form_type":"4"}},{"id":434527,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-07T15:56:02.000Z","date":"2016-10-05","kind":"sale","acquired":false,"shares":800,"price":86.68,"value":69344.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $86.68 (range $86.25 to $87.15)."}],"balance_after":273925,"source":{"system":"sec-edgar","filing":"0001209191-16-145346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116145346/doc4.xml","form_type":"4"}},{"id":434526,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-07T15:56:02.000Z","date":"2016-10-05","kind":"exercise","acquired":true,"shares":6500,"price":36.3,"value":235950.0,"ownership":{"direct":true},"balance_after":274725,"source":{"system":"sec-edgar","filing":"0001209191-16-145346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116145346/doc4.xml","form_type":"4"}},{"id":434811,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-30T20:44:17.000Z","date":"2016-09-28","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":99000,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-16-143339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116143339/doc4.xml","form_type":"4"}},{"id":434810,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-30T20:44:17.000Z","date":"2016-09-28","kind":"sale","acquired":false,"shares":600,"price":89.11,"value":53466.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $89.11 (range $89.05 to $89.19)."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-16-143339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116143339/doc4.xml","form_type":"4"}},{"id":434809,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-30T20:44:17.000Z","date":"2016-09-28","kind":"sale","acquired":false,"shares":2937,"price":88.55,"value":260071.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $88.55 (range $88.01 to $88.99)."}],"balance_after":268825,"source":{"system":"sec-edgar","filing":"0001209191-16-143339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116143339/doc4.xml","form_type":"4"}},{"id":434808,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-30T20:44:17.000Z","date":"2016-09-28","kind":"sale","acquired":false,"shares":2963,"price":87.56,"value":259440.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $87.56 (range $87.01 to $88.00)."}],"balance_after":271762,"source":{"system":"sec-edgar","filing":"0001209191-16-143339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116143339/doc4.xml","form_type":"4"}},{"id":434807,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-30T20:44:17.000Z","date":"2016-09-28","kind":"exercise","acquired":true,"shares":6500,"price":36.3,"value":235950.0,"ownership":{"direct":true},"balance_after":274725,"source":{"system":"sec-edgar","filing":"0001209191-16-143339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116143339/doc4.xml","form_type":"4"}},{"id":434900,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-23T20:50:07.000Z","date":"2016-09-21","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully vested."}],"balance_after":105500,"derivative":{"exercise_price":36.3,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-16-142628","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116142628/doc4.xml","form_type":"4"}},{"id":434899,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-23T20:50:07.000Z","date":"2016-09-21","kind":"sale","acquired":false,"shares":200,"price":92.31,"value":18462.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $92.31 (range $92.27 to $92.35)."}],"balance_after":268225,"source":{"system":"sec-edgar","filing":"0001209191-16-142628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919116142628/doc4.xml","form_type":"4"}}],"next_cursor":"2016-09-23T20:50:07.000000Z,434899"}